Announced Fri, 10 Jul · 10:14 IST
RTA confirms all shares held electronically in Q1 FY27 compliance filing
Compliance View source PDF
SUDEEPPHRM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+4.9%1-day move
₹807.00
prior close
₹822.00
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+1.0+0.9+0.9+0.9+4.9+4.1+5.0+9.6+6.6+7.8————
Up moveDown movePending
AI summary
Sudeep Pharma submitted a routine compliance certificate under SEBI Regulation 74(5) for the quarter ended 30 June 2026. The Registrar and Share Transfer Agent, MUFG Intime India Private Limited, confirmed that no demat requests were received during the quarter because all shares of the company are already held in electronic mode. This is a standard quarterly filing required by SEBI for listed companies whose shares are traded on the exchange.
Likely market impact
Routine regulatory filing with no material impact on shareholders or stock price.